Anxiety, loss of motivation, loss of aggression, lack of feelings of wellbeing, severe anhedonia and visuospatial and cognitive impairment are some the most frequent neuropsychological complaints in PFS. These can manifest with a profound severity and entail a devastating impact on quality of life. This is strongly suggestive of impairment in executive, reward and motivational circuitry in the brain. The important role of metabolite neurosteroids (Diotel et al., 2018), shown to be broadly deregulated in PFS (Melcangi et al., 2017), may have additional relevance to these symptomatic areas. However, this is beyond the scope of this review, which is focused upon a potential pleiotropic pathomechanism with direct relevance to the full clinical picture and underlying the pathology.
Low serum testosterone is strongly associated with an increase in depression in aging men (Ford et al., 2016) and men undergoing ADT (Lee et al., 2014). Androgens have mostly anxiolytic and antidepressant properties in humans and animals (Liang et al., 2018; McHenry et al., 2014; Zarrouf et al., 2009). Androgens regulate gene expression in key areas of the brain that are fundamental to the etiology of depression and anxiety (McHenry et al., 2014). AR-deficient mice rapidly develop depressive-like behaviour with exposure to chronic mild stress (Hung et al., 2019) and significant comparative reductions in AR in the hypothalamic paraventricular nucleus (PVN) has been identified in autopsied depression patients (Wang et al., 2008). Androgen administration has anti-depressive effects in middle-aged men with low testosterone levels (Amanatkar et al., 2014). Owens et al. reported significantly increased AR mRNA in the PFC of patients with bipolar disorder as surprising given the association of depression with low androgen levels but noted the association of excessive androgen signaling with psychological illness (Owens et al., 2019).
Impaired executive functioning and visuospatial abilities are the most frequently reported cognitive consequences of androgen deprivation therapy (Nelson et al., 2008). Additionally, multiple lines of evidence including in anabolic steroid abuse and polycystic ovary syndrome suggests increased androgen action is markedly associated with psychological illnesses including schizophrenia, psychosis, bipolar disorder, tics, anxiety and depression (Cesta et al., 2016; Piacentino et al., 2015; Wood, 2008). In an important review of the role of androgens in the mesolimbic system and of evidence that both high and low androgen signaling causes cognitive impairment in both human and animals, Tobiansky et al. suggested that optimally required levels of androgen signaling are required within the mesolimbic system (Tobiansky et al., 2018). Mesolimbic areas crucial to executive function including the ventral tegmental area (VTA), nucleus accumbens (NAc), and prefrontal cortex (PFC) express AR (Kritzer, 1997; Low et al., 2017; Tobiansky et al., 2018), areas which functionally align with the effects of androgens on behaviour (Kritzer, 1997). As the AR relevant to function in these areas is often not concentrated in neuronal nuclei, this has been traditionally difficult to quantify and easily overlooked. Executive functioning, which includes behavioural prioritisation of goal attainment, attention, inhibitory control and working memory, critically depends on PFC function (Tobiansky et al., 2018). Importantly, all major prefrontal cortical projections in the VTA are substantially AR enriched. Androgen signaling regulates the essential dopamine innervation of the PFC and regulates glutamate signaling, potentially through these circuits (Aubele & Kritzer, 2011). The NAc is critically involved in reward behaviour and is an integrative and convergent site for reward systems in the brain (Sesack & Grace, 2009). Neurons in the NAc respond to both excitatory and inhibitory afferents from the ventral hippocampus (vHPC) (Scudder et al., 2018). In the rat, AR is colocalised with dopamine neurons in the midbrain that project to the amygdala and nucleus accumbens (Creutz & Kritzer, 2004). In line with human studies suggesting an increase in testosterone raises striatal dopamine (Hermans et al., 2010), studies in the male rat have demonstrated AR-driven modulation of molecular measures of dopamine responsivity of the nigrostriatal pathway including regulating mRNA, levels of molecules involved in pre-synaptic dopamine synthesis, dopamine reuptake, packaging, breakdown and reception (Purves-Tyson et al., 2014). Dopamine is increased in reward regions of the rat brain in under 30 minutes (de Souza Silva et al., 2009), and the testosterone-induced effect on reward behaviour is abolished by administration of the dopamine receptor antagonist α-flupentixol (Packard et al., 1998). Coincident with a sharp decline in voluntary physical activity, AR knockout mice show a substantial loss of dopamine and dopamine receptor expression in the striatum, with upregulation of mRNA levels of the metabolic enzymes monoamine oxidase A and B (Jardí et al., 2018). Alongside a significant reduction in voluntary activity, mice with knockout of hypothalamus-specific AR exhibited a large decrease in D₁ receptor mRNA and an increase in MOAB mRNA (Clarke et al., 2019). Interestingly, androgen-anabolic steroids significantly decrease D₁ receptor in the NAc (Kindlundh et al., 2001) and testosterone administration impairs D₁ receptor-dependent set-shifting behaviour in rats (Wallin & Wood, 2015). DHT treatment inhibits the open-field induced dopamine increase in the PFC (Handa et al., 1997). This has important implications for cognitive functioning considering the importance of PFC functions. Loss of adequate D₁ receptor function in the PFC of Rhesus macaques causes cognitive deficits close to surgical ablation of the site (Brozoski et al., 1979; Tobiansky et al., 2018).
In late adolescent rats, finasteride remarkably decreases the activity of the dopaminergic system, exploratory and motor behaviours through decreasing DHT production and consequently androgen receptor activation on dopamine neurons in the Substantia nigra and VTA. Interestingly, this effect was not seen in older or younger rats (Li et al., 2017). The reported reduction in brain DHT of late adolescent rats had not been observed in younger rats in a previous study (Giatti et al., 2015), suggesting significant interruption in brain dopaminergic activity occurs when AR activation is inhibited during the time testosterone levels are at their natural peak (Li et al., 2017). This spatiotemporal observation of age-related difference is of potential relevance to the prevalence of PFS in young adult men of fertile age.
Androgens have been demonstrated to modulate the HPA stress response and modulate anxiety behaviours (Mhaouty-Kodja, 2018). While all metabolites of testosterone, including DHT, influence anxiety-like behaviours in animal models, aged male rats are more anxious than female counterparts. This difference is abolished by prepubertal orchiectomy, demonstrating this difference is androgen dependent (Domonkos et al., 2017). Evidence suggests the anxiolytic effect of T is mediated at least in part through the AR. Men treated with flutamide experience increased anxiety (Almeida et al., 2004). Intrahippocampal flutamide increases anxiety behaviour of intact and DHT-replaced male rats, but not when independently administered to gonadectomised rats (Edinger & Frye, 2006). Corticotropin-releasing hormone is an important regulator of the HPA axis and response. AR mediates regulation of corticotropin-releasing hormone mRNA in the PVN, possibly via AR-colocalising projecting neurons in the bed nucleus of the stria terminalis (Heck & Handa, 2019).
Williams et al. demonstrated sex differences in the resilience to stress-induced anhedonia in mice and revealed an androgen-mediated mechanism underlying lower vHPC-NAc excitability and correlated increase in subchronic stress resistance in male mice. Reduced sucrose preference following subchronic variable stress (SVS) was demonstrated to be female specific. Orchidectomy rendered male mice vulnerable to SVS-induced anhedonia. Testosterone to female mice was protective of SVS-induced anhedonia and decreased vHPC-NAc excitability in females. Ovariectomy, by contrast, did not affect female vHPC-NAc neuron excitability, suggesting direct mediation by the AR. It was determined that vHPC-NAc projection neurons, and many surrounding vHPC CA1 pyramidal cells highly express AR, and that bath application of the antiandrogen flutamide increased the excitability of cells (Williams et al., 2020), further suggesting interruption of androgen signalling conferred this susceptibility. The identification of this specific androgen-driven circuitry and its causal link to anhedonia suggests that a tissue-specific deregulation of the AR, as we propose in PFS, would have significant implications for dopaminergic signalling in the NAc and consequently anhedonia symptoms.
Providing a vital addition to the understanding of both the rapid effect of nonclassical androgen signaling on human social behaviour and the AR-dependency of testosterone’s influence on aggression, Geniole et al. demonstrated that a single administration of testosterone to men with high-risk personality profiles increased aggression. This effect was negatively correlated with AR CAG repeat length, with shorter CAG repeat subjects exhibiting an enhanced effect. These effects were associated with increase reward feelings associated with aggression as opposed to anger associated with aggression, suggesting a rapid AR-mediated modulation of dopamine pathways in line with existing evidence (Geniole et al., 2019).
Conclusively, significant evidence indicates the curvilinear tissue response of androgen action is relevant to anxiety and mood (Owens et al., 2019) as well as cognitive function (Tobiansky et al., 2018).
Severe memory impairment is a common and problem reported by PFS patients, with many extremely serious implications for the patient’s life. The hippocampus is critical to a broad range of learning, memory, visual, spatial, and navigatory functions in mammals (Eichenbaum, 2017; Rolls & Wirth, 2018). In humans, CA1 neurons are crucial to memory formation and retrieval, as well as self-continuity, autonoetic consciousness and detailed memory revisitation (Bartsch et al., 2011). The AR is highly expressed in the hippocampus, particularly in CA1 pyramidal neurons. In addition to nuclear and cytoplasmic presence, AR is localised in spines, and synaptic AR rapidly responds to androgen, directly modulating spine density by kinase network activation (Hatanaka et al., 2015; Soma et al., 2018). Pyramidal CA1 neurons require NMDA receptors for spatial and temporal memory (Huerta et al., 2000). Neural AR deletion in mice impaired NMDAR activation and prevented temporal differentiation between objects seen, revealing hippocampal CA1 AR is critical for processing of visual temporal information, possibly through an observed modulation of glutamatergic transmission (Picot et al., 2016).
AR overexpression is demonstrated to strongly alter memory-related genes in the CA1 region (Ramzan et al., 2018). Finasteride has been demonstrated to significantly decrease brain DHT levels and reversibly reduce neurogenesis in the hippocampus of mice, affecting neuronal plasticity on a structural level (Römer et al., 2010). Hippocampal AR in humans is highly expressed in both sexes. Remarkably, this is of the same order of magnitude as AR expression in the prostate of BPH patients (Beyenburg et al., 2000). Multiple studies suggest androgens as important organisational modulators of hippocampal physiology that maintain active hippocampal functions throughout life (Hamson et al., 2016; Kerr et al., 1995). Perceived male sex-related advantages in spatio-visual and navigatory abilities have been attributed to androgens rather than evolutionary adaptation (Clint et al., 2012). Reports on the effects of androgens on spatial ability have provided contradictory results, suggestive of complex regulation (Shahrzad & Nasser, 2015). Men with Alzheimer’s disease have lower brain testosterone, and findings suggest that low androgens may predispose to Alzheimer’s (Rosario et al., 2011). In Alzheimer’s models, testosterone has been demonstrated to exert a protective effect via an AR-mediated increase hippocampal neurons, synaptic plasticity and dendritic spine density (Jia et al., 2019). However, prelimbic testosterone injection causes impairment in spatial learning and memory in male Wistar rats (Gholaminejad et al., 2019). Clearly, crucial sites involved in learning, memory and spatial processing are markedly sensitive to alteration in androgen signaling.
PFS has driven patients to suicide through the rapid and persistent destruction of their ability to sleep. In severely affected patients, this can be total. A patient who had resumed finasteride for a very short time with a stated aim of maintaining his hair for upcoming wedding photographs committed suicide after describing the rapid onset of extreme health complaints including debilitating anxiety and insomnia that prevented any sleep for a month. Severely affected patients often describe poor-quality, brief and interrupted sleep many years after brief use of the drug. This is an important and disabling symptom, the severity of which does not appear to be appreciated in literature. Additionally, patients have reported onset or worsening of sleep apnoea. Irwig found that insomnia was a common complaint in the medical records of 6 patients who committed suicide following use of Finasteride and development of persistent symptoms, and this was amongst their most debilitating symptoms (Irwig, 2020). Evidence suggests that, as well as low testosterone being associated with a decrease in sleep quality (Barrett-Connor et al., 2008), increased androgen signaling may be associated with sleep disruption and disordered breathing. Higher testosterone levels are associate with lower sleep intensity and higher ventilatory instability in men (Morselli et al., 2018), and whole genome methylation analysis has shown elevated AR protein is associated with obstructive sleep apnoea (OSA) via ventilatory instability (Chen et al., 2016). High dose exogenous testosterone can cause significant disruption of sleep to the extent of clinically relevant harm, as well as inducing and exacerbating OSA (Kim & Cho, 2019; Liu et al., 2003). Exogenous T has induced sleep apnoea in a female patient (Johnson et al., 1984). In the hyperandrogenic condition PCOS, meta-analysis of research has indicated a significant association of OSA with the syndrome (Helvaci et al., 2017). As previously mentioned, a high occurrence of sleep disorders has been reported in SBMA patients (Romigi et al., 2014). Androgens act locally in the suprachiasmatic nucleus, the hypothalamic structure controlling behavioural and physiological circadian rhythms, to influence plastic structural reorganisation and alter circadian period (Model et al., 2015). Androgen receptors are present in the suprachiasmatic nucleus, are regulated locally by androgens, and thus are an obvious site of action for a direct effect of androgen steroids (Karatsoreos & Silver, 2007). Significant clinical differences in the response of healthy men and women to a single dose of Olanzapine (Giménez et al., 2011) suggest sex differences in the mechanisms regulating sleep (Mong & Cusmano, 2016). The exact influence of sex steroids over sleep remains an important knowledge gap (Mong & Cusmano, 2016).
A central and potentially causative role of androgen signaling was recently demonstrated in idiopathic intracranial hypertension (IIH), which entails an increase of CSF pressure. O’Reilly et al. identified a pattern of androgen excess in female IIH patients. Like human choroid plexus, rat cells expressed AR along with androgen-metabolising enzymes. It was demonstrated that testosterone drove CSF output in rodent choroid plexus cells (O’Reilly et al., 2019). O’Reilly et al. noted that while a determinant role for androgens in IIH may seem biologically implausible considering IIH occurs less frequently in men, androgens are now known to exert sexually dimorphic effects on metabolism. The metabolic phenotype of hypogonadal men resembles that of women with androgen excess, including an increased risk of type 2 diabetes, non-alcoholic fatty liver disease and cardiovascular mortality (Ding et al., 2006; Kautzky-Willer et al., 2016). O’Reilly et al. suggest epigenetic modifications to local androgen action or differences in AR signaling in both sexes as a plausible explanation, with IIH potentially representing a distinctive manifestation of these sex specific differences (O’Reilly et al., 2019). Interestingly, male IIH patients are more likely to have symptoms typically associated with androgen insufficiency including obstructive sleep apnoea, erectile dysfunction and loss of libido (Fraser et al., 2010). As well, androgen deprivation therapy or hypogonadism can induce IIH symptomatology (Valcamonico et al., 2013). Although in males the metabolic parabola of AR signaling is shifted far to the right compared with females (Ding et al., 2006; Morford et al., 2018), significant increases in AR signaling in men are likely to recapitulate this symptomatology, and we therefore consider it plausible IIH occurs in PFS and contributes to commonly reported symptoms, including feelings of intense pressure in the head. In this context, it is of interest that the pilot study of Melcangi et al. evaluating CSF methylation in PFS patients and controls found only one member of the control group with methylation of SRD5A2, and this patient had normal-pressure hydrocephalus. The majority of PFS patient samples exhibited variable methylation of this gene (Melcangi et al., 2019).
It is of interest that SRD5A2 was reported to be methylated in most CSF samples in a cohort of PFS patients. Interestingly, symptoms and severity per validated scales were found not to correlate to the observed methylation profiles (Melcangi et al., 2019). This is unlikely to represent a key factor in the pathological presentation when considering the symptomatic profile, novel factors of the condition and the lack of significant overlap between PFS and 5 alpha reductase insufficiency (Brinkmann et al., 2007; Imperato-McGinley et al., 1974).
5 alpha reductase type II is localised to many areas abundant in dopamine neurons and sites of projection, and finasteride has been considered for application in conditions associated with increased dopaminergic signaling including Parkinson’s disease, Tourette’s syndrome and schizophrenia (Castelli et al., 2013). Reduced D2 dopamine receptor binding in the nucleus accumbens has been reported in 5ar2 knockout mice. This was accompanied with behavioural deficits in aggressive, dominance, mating behaviours, along with reduced novelty seeking and risk taking. No anxiety-like, motoric or processing deficits were observed in these mice, and 5ar2 deficiency is not associated with sensorimotor deficit nor abnormalities in anxiety-like or reward-related behaviours (Mosher et al., 2018). Further, sexual desire is usually normal in human patients (Brinkmann et al., 2007). A role in neurosteroidgenesis could have some symptomatic relevance given their behavioural influences (Edinger & Frye, 2005; Ratner et al., 2019). However, hypotheses regarding the pathological alterations in PFS being localised to the nervous system do not plausibly account for the symptoms of patients, nor take appropriate account of reported evidence from investigations of peripheral tissues.
Evidence suggests that the methylation status of SRD5A2 is under regulatory influence of androgen signaling. Both serum DHT and SRD5A2 mRNA in seminal vesicles have been demonstrated to significantly increase in inducible ARKO mice, demonstrating that SRD5A2 is regulated by the AR through local negative feedback (Wu et al., 2019). 5ar2 expression in the rat brain has been demonstrated to be under feed-forward regulation of androgens (Torres & Ortega, 2003). In the frog Silurana tropicalis, Bissegger and Langlois demonstrated that while SRD5A2 was not altered at the mRNA level, DNA methylation of SRD5A2 significantly increased in the testes and ovaries following treatment with DHT, suggesting androgen modulation of epigenetic mechanisms in both sexes. The methylation statuses of SRD5A1 and SRD5A3 were not changed following androgen exposure (Bissegger & Langlois, 2016).
One possible mechanistic influence of androgen signaling on methylation of SRD5A2 is the role of androgens in inflammatory regulation and a consequential influence on the methyltransferase enzyme DNA methyltransferase 1 (DNMT1). Kang et al. found a majority of BPH samples have methylation of the SRD5A2 promoter, with strong correlation between methylation and low or absent expression of 5alpha reductase 2 (Kang et al., 2018). Ge et al. reported that, in human prostate samples, DNMT1 regulates methylation of SRD5A2. The methylation of the promotor was shown to be increased by inflammatory mediators such as tumor necrosis factor α (TNF-α), Nuclear factor-kappa B (NF-κB), and Interleukin-6 (IL-6) which upregulate DNMT1 expression. Inhibition of TNF-α restored the expression of SRD5A2 (Ge et al., 2015). In prostate cancer cells, androgen signaling crosstalk exists with inflammatory signaling (Malinen et al., 2017). As previously discussed, the AR has an upregulatory effect on TNF-α expression and is thus suppressive of cutaneous wound healing (Lai et al., 2009). DHT activates macrophage TNF-α secretion through AR signaling in prostatic urethral tissue (Zhao et al., 2017). In the CNS, epigenetic macrophage activation increases proinflammatory cytokines and chemokines, including TNF-α and IL-6 (Yin et al., 2017).
- Almeida, O. P., Waterreus, A., Spry, N., Flicker, L., & Martins, R. N. (2004). One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology, 1071–1081. https://doi.org/10.1016/j.psyneuen.2003.11.002
- Amanatkar, H., Chibnall, J., Seo, B., Manepalli, J., & Grossberg, G. (2014). Impact of exogenous testosterone on mood: a systematic review and meta-analysis of randomized placebo-controlled trials. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists, 26(1), 19–32. https://www.ncbi.nlm.nih.gov/pubmed/24501728
- Aubele, T., & Kritzer, M. F. (2011). Androgen Influence on Prefrontal Dopamine Systems in Adult Male Rats: Localization of Cognate Intracellular Receptors in Medial Prefrontal Projections to the Ventral Tegmental Area and Effects of Gonadectomy and Hormone Replacement on Glutamate-Stimulated Extracellular Dopamine Level. Cerebral Cortex, 1799–1812. https://doi.org/10.1093/cercor/bhr258
- Barrett-Connor, E., Dam, T.-T., Stone, K., Harrison, S. L., Redline, S., & Orwoll, E. (2008). The Association of Testosterone Levels with Overall Sleep Quality, Sleep Architecture, and Sleep-Disordered Breathing. The Journal of Clinical Endocrinology & Metabolism, 2602–2609. https://doi.org/10.1210/jc.2007-2622
- Bartsch, T., Dohring, J., Rohr, A., Jansen, O., & Deuschl, G. (2011). CA1 neurons in the human hippocampus are critical for autobiographical memory, mental time travel, and autonoetic consciousness. Proceedings of the National Academy of Sciences, 17562–17567. https://doi.org/10.1073/pnas.1110266108
- Beyenburg, S., Watzka, M., Clusmann, H., Blümcke, I., Bidlingmaier, F., Elger, C. E., & Stoffel-Wagner, B. (2000). Androgen receptor mRNA expression in the human hippocampus. Neuroscience Letters, 25–28. https://doi.org/10.1016/s0304-3940(00)01542-1
- Bissegger, S., & Langlois, V. S. (2016). Androgens modulate gene expression and specific DNA methylation pattern of steroid 5α-reductases in the frog Silurana tropicalis. General and Comparative Endocrinology, 123–132. https://doi.org/10.1016/j.ygcen.2016.03.021
- Brinkmann, L., Schuetzmann, K., & Richter-Appelt, H. (2007). ORIGINAL RESEARCH—INTERSEX AND GENDER IDENTITY DISORDERS: Gender Assignment and Medical History of Individuals with Different Forms of Intersexuality: Evaluation of Medical Records and the Patients’ Perspective. The Journal of Sexual Medicine, 964–980. https://doi.org/10.1111/j.1743-6109.2007.00524.x
- Brozoski, T., Brown, R., Rosvold, H., & Goldman, P. (1979). Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science, 929–932. https://doi.org/10.1126/science.112679
- Castelli, M. P., Casti, A., Casu, A., Frau, R., Bortolato, M., Spiga, S., & Ennas, M. G. (2013). Regional distribution of 5α-reductase type 2 in the adult rat brain: An immunohistochemical analysis. Psychoneuroendocrinology, 281–293. https://doi.org/10.1016/j.psyneuen.2012.06.008
- Cesta, C. E., Månsson, M., Palm, C., Lichtenstein, P., Iliadou, A. N., & Landén, M. (2016). Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology, 196–203. https://doi.org/10.1016/j.psyneuen.2016.08.005
- Chen, Y.-C., Chen, T.-W., Su, M.-C., Chen, C.-J., Chen, K.-D., Liou, C.-W., Tang, P., Wang, T.-Y., Chang, J.-C., Wang, C.-C., Lin, H.-C., Chin, C.-H., Huang, K.-T., Lin, M.-C., & Hsiao, C.-C. (2016). Whole Genome DNA Methylation Analysis of Obstructive Sleep Apnea:IL1R2,NPR2,AR,SP140Methylation and Clinical Phenotype. Sleep, 743–755. https://doi.org/10.5665/sleep.5620
- Clarke, M. V., Russell, P. K., Zajac, J. D., & Davey, R. A. (2019). The androgen receptor in the hypothalamus positively regulates hind-limb muscle mass and voluntary physical activity in adult male mice. The Journal of Steroid Biochemistry and Molecular Biology, 187–194. https://doi.org/10.1016/j.jsbmb.2019.02.018
- Clint, E. K., Sober, E., Garland, T., Jr., & Rhodes, J. S. (2012). Male Superiority in Spatial Navigation: Adaptation or Side Effect? The Quarterly Review of Biology, 289–313. https://doi.org/10.1086/668168
- Creutz, L. M., & Kritzer, M. F. (2004). Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats. The Journal of Comparative Neurology, 348–362. https://doi.org/10.1002/cne.20229
- de Souza Silva, M. A., Mattern, C., Topic, B., Buddenberg, T. E., & Huston, J. P. (2009). Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone. European Neuropsychopharmacology, 53–63. https://doi.org/10.1016/j.euroneuro.2008.08.003
- Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006). Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes. JAMA, 1288. https://doi.org/10.1001/jama.295.11.1288
- Diotel, N., Charlier, T. D., Lefebvre d’Hellencourt, C., Couret, D., Trudeau, V. L., Nicolau, J. C., Meilhac, O., Kah, O., & Pellegrini, E. (2018). Steroid Transport, Local Synthesis, and Signaling within the Brain: Roles in Neurogenesis, Neuroprotection, and Sexual Behaviors. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2018.00084
- Domonkos, E., Borbélyová, V., Csongová, M., Bosý, M., Kačmárová, M., Ostatníková, D., Hodosy, J., & Celec, P. (2017). Sex differences and sex hormones in anxiety-like behavior of aging rats. Hormones and Behavior, 159–165. https://doi.org/10.1016/j.yhbeh.2017.05.019
- Edinger, K. L., & Frye, C. A. (2005). Testosterone’s anti-anxiety and analgesic effects may be due in part to actions of its 5α-reduced metabolites in the hippocampus. Psychoneuroendocrinology, 418–430. https://doi.org/10.1016/j.psyneuen.2004.11.001
- Edinger, K. L., & Frye, C. A. (2006). Intrahippocampal administration of an androgen receptor antagonist, flutamide, can increase anxiety-like behavior in intact and DHT-replaced male rats. Hormones and Behavior, 216–222. https://doi.org/10.1016/j.yhbeh.2006.03.003
- Eichenbaum, H. (2017). The role of the hippocampus in navigation is memory. Journal of Neurophysiology, 1785–1796. https://doi.org/10.1152/jn.00005.2017
- Ford, A. H., Yeap, B. B., Flicker, L., Hankey, G. J., Chubb, S. A. P., Handelsman, D. J., Golledge, J., & Almeida, O. P. (2016). Prospective longitudinal study of testosterone and incident depression in older men: The Health In Men Study. Psychoneuroendocrinology, 57–65. https://doi.org/10.1016/j.psyneuen.2015.11.012
- Fraser, J. A., Bruce, B. B., Rucker, J., Fraser, L.-A., Atkins, E. J., Newman, N. J., & Biousse, V. (2010). Risk factors for idiopathic intracranial hypertension in men: A case–control study. Journal of the Neurological Sciences, 86–89. https://doi.org/10.1016/j.jns.2009.11.001
- Ge, R., Wang, Z., Bechis, S. K., Otsetov, A. G., Hua, S., Wu, S., Wu, C.-L., Tabatabaei, S., & Olumi, A. F. (2015). DNA Methyl Transferase 1 Reduces Expression of SRD5A2 in the Aging Adult Prostate. The American Journal of Pathology, 870–882. https://doi.org/10.1016/j.ajpath.2014.11.020
- Geniole, S. N., Procyshyn, T. L., Marley, N., Ortiz, T. L., Bird, B. M., Marcellus, A. L., Welker, K. M., Bonin, P. L., Goldfarb, B., Watson, N. V., & Carré, J. M. (2019). Using a Psychopharmacogenetic Approach To Identify the Pathways Through Which—and the People for Whom—Testosterone Promotes Aggression. Psychological Science, 481–494. https://doi.org/10.1177/0956797619826970
- Gholaminejad, A., Gholamipour-Badie, H., Nasehi, M., & Naghdi, N. (2019). Prelimbic of medial prefrontal cortex GABA modulation through testosterone on spatial learning and memory. Iranian Journal of Pharmaceutical Research, 18(3), 1429–1444. https://doi.org/10.22037/IJPR.2019.1100745
- Giatti, S., Foglio, B., Romano, S., Pesaresi, M., Panzica, G., Garcia-Segura, L. M., Caruso, D., & Melcangi, R. C. (2015). Effects of Subchronic Finasteride Treatment and Withdrawal on Neuroactive Steroid Levels and Their Receptors in the Male Rat Brain. Neuroendocrinology, 746–757. https://doi.org/10.1159/000442982
- Giménez, S., Romero, S., Gich, I., Clos, S., Grasa, E., Rosa-María, A., & Barbanoj, M.-J. (2011). Sex differences in sleep after a single oral morning dose of olanzapine in healthy volunteers. Human Psychopharmacology: Clinical and Experimental, 498–507. https://doi.org/10.1002/hup.1232
- Hamson, D. K., Roes, M. M., & Galea, L. A. M. (2016). Sex Hormones and Cognition: Neuroendocrine Influences on Memory and Learning. In Comprehensive Physiology (pp. 1295–1337). John Wiley & Sons, Inc. https://doi.org/10.1002/cphy.c150031
- Handa, R. J., Hejna, G. M., & Lorens, S. A. (1997). Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment. Brain Research, 131–138. https://doi.org/10.1016/s0006-8993(96)01394-7
- Hatanaka, Y., Hojo, Y., Mukai, H., Murakami, G., Komatsuzaki, Y., Kim, J., Ikeda, M., Hiragushi, A., Kimoto, T., & Kawato, S. (2015). Rapid increase of spines by dihydrotestosterone and testosterone in hippocampal neurons: Dependence on synaptic androgen receptor and kinase networks. Brain Research, 121–132. https://doi.org/10.1016/j.brainres.2014.12.011
- Heck, A. L., & Handa, R. J. (2019). Androgens Drive Sex Biases in Hypothalamic Corticotropin-Releasing Hormone Gene Expression After Adrenalectomy of Mice. Endocrinology, 1757–1770. https://doi.org/10.1210/en.2019-00238
- Helvaci, N., Karabulut, E., Demir, A. U., & Yildiz, B. O. (2017). Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature. Endocrine Connections, 437–445. https://doi.org/10.1530/ec-17-0129
- Hermans, E. J., Bos, P. A., Ossewaarde, L., Ramsey, N. F., Fernández, G., & van Honk, J. (2010). Effects of exogenous testosterone on the ventral striatal BOLD response during reward anticipation in healthy women. NeuroImage, 277–283. https://doi.org/10.1016/j.neuroimage.2010.04.019
- Huerta, P. T., Sun, L. D., Wilson, M. A., & Tonegawa, S. (2000). Formation of Temporal Memory Requires NMDA Receptors within CA1 Pyramidal Neurons. Neuron, 473–480. https://doi.org/10.1016/s0896-6273(00)80909-5
- Hung, Huang, Chang, & Kang. (2019). Deficiency in Androgen Receptor Aggravates the Depressive-Like Behaviors in Chronic Mild Stress Model of Depression. Cells, 1021. https://doi.org/10.3390/cells8091021
- Imperato-McGinley, J., Guerrero, L., Gautier, T., & Peterson, R. E. (1974). Steroid 5agr-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism. Science, 1213–1215. https://doi.org/10.1126/science.186.4170.1213
- Irwig, M. S. (2020). Finasteride and Suicide: A Postmarketing Case Series. Dermatology, 1–6. https://doi.org/10.1159/000505151
- Jardí, F., Laurent, M. R., Kim, N., Khalil, R., De Bundel, D., Van Eeckhaut, A., Van Helleputte, L., Deboel, L., Dubois, V., Schollaert, D., Decallonne, B., Carmeliet, G., Van den Bosch, L., D’Hooge, R., Claessens, F., & Vanderschueren, D. (2018). Testosterone boosts physical activity in male mice via dopaminergic pathways. Scientific Reports. https://doi.org/10.1038/s41598-017-19104-0
- Jia, J.-X., Yan, X.-S., Yang, Z.-J., Song, W., Fang, X., Cai, Z.-P., Huo, D.-S., & Wang, H. (2019). Protective mechanism of testosterone on cognitive impairment in a rat model of Alzheimer’s disease. Neural Regeneration Research, 649. https://doi.org/10.4103/1673-5374.245477
- Johnson, M., Anch, A., & Remmers, J. (1984). Induction of the obstructive sleep apnea syndrome in a woman by exogenous androgen administration. The American Review of Respiratory Disease, 129(6), 1023–1025. https://doi.org/10.1164/arrd.19220.127.116.113
- Kang, P. M., Kim, Y. J., Seo, W. T., Kang, S. H., Kim, T. S., Chun, B. K., Seo, W. I., Jeong, J.-Y., & Chung, J. I. (2018). Correlation between 5-α reductase type 2 protein expression and methylation of 5-α reductase type 2 promotor gene of benign prostatic hyperplasia. World Journal of Urology, 709–718. https://doi.org/10.1007/s00345-018-2422-4
- Karatsoreos, I. N., & Silver, R. (2007). Minireview: The Neuroendocrinology of the Suprachiasmatic Nucleus as a Conductor of Body Time in Mammals. Endocrinology, 5640–5647. https://doi.org/10.1210/en.2007-1083
- Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016). Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocrine Reviews, 278–316. https://doi.org/10.1210/er.2015-1137
- Kerr, J. E., Allore, R. J., Beck, S. G., & Handa, R. J. (1995). Distribution and hormonal regulation of androgen receptor (AR) and AR messenger ribonucleic acid in the rat hippocampus. Endocrinology, 3213–3221. https://doi.org/10.1210/endo.136.8.7628354
- Kim, S.-D., & Cho, K.-S. (2019). Obstructive Sleep Apnea and Testosterone Deficiency. The World Journal of Men’s Health, 12. https://doi.org/10.5534/wjmh.180017
- Kindlundh, A. M. S., Lindblom, J., Bergström, L., Wikberg, J. E. S., & Nyberg, F. (2001). The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. European Journal of Neuroscience, 291–296. https://doi.org/10.1046/j.0953-816x.2000.01402.x
- Kritzer, M. F. (1997). Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat. The Journal of Comparative Neurology, 247–260.Lai, J.-J., Lai, K.-P., Chuang, K.-H., Chang, P., Yu, I.-C., Lin, W.-J., & Chang, C. (2009). Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-α expression. Journal of Clinical Investigation, 3739–3751. https://doi.org/10.1172/jci39335Lee, M., Jim, H. S., Fishman, M., Zachariah, B., Heysek, R., Biagioli, M., & Jacobsen, P. B. (2014). Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison. Psycho-Oncology, 472–477. https://doi.org/10.1002/pon.3608Li, L., Kang, Y.-X., Ji, X.-M., Li, Y.-K., Li, S.-C., Zhang, X.-J., Cui, H.-X., & Shi, G.-M. (2017). Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats. CNS Neuroscience & Therapeutics, 115–125. https://doi.org/10.1111/cns.12781Liang, Y., Li, J., Jin, T., Gu, T., Zhu, Q., Hu, Y., Yang, Y., Li, J., Wu, D., Jiang, K., & Xu, X. (2018). Bisphenol-A inhibits improvement of testosterone in anxiety- and depression-like behaviors in gonadectomied male mice. Hormones and Behavior, 129–138. https://doi.org/10.1016/j.yhbeh.2018.05.012Liu, P. Y., Yee, B., Wishart, S. M., Jimenez, M., Jung, D. G., Grunstein, R. R., & Handelsman, D. J. (2003). The Short-Term Effects of High-Dose Testosterone on Sleep, Breathing, and Function in Older Men. The Journal of Clinical Endocrinology & Metabolism, 3605–3613. https://doi.org/10.1210/jc.2003-030236Low, K. L., Ma, C., & Soma, K. K. (2017). Tyramide Signal Amplification Permits Immunohistochemical Analyses of Androgen Receptors in the Rat Prefrontal Cortex. Journal of Histochemistry & Cytochemistry, 295–308. https://doi.org/10.1369/0022155417694870McHenry, J., Carrier, N., Hull, E., & Kabbaj, M. (2014). Sex differences in anxiety and depression: Role of testosterone. Frontiers in Neuroendocrinology, 42–57. https://doi.org/10.1016/j.yfrne.2013.09.001Melcangi, R. C., Casarini, L., Marino, M., Santi, D., Sperduti, S., Giatti, S., Diviccaro, S., Grimoldi, M., Caruso, D., Cavaletti, G., & Simoni, M. (2019). Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study. Endocrine Connections, 1118–1125. https://doi.org/10.1530/ec-19-0199Melcangi, R. C., Santi, D., Spezzano, R., Grimoldi, M., Tabacchi, T., Fusco, M. L., Diviccaro, S., Giatti, S., Carrà, G., Caruso, D., Simoni, M., & Cavaletti, G. (2017). Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients. The Journal of Steroid Biochemistry and Molecular Biology, 229–235. https://doi.org/10.1016/j.jsbmb.2017.04.003Mhaouty-Kodja, S. (2018). Role of the androgen receptor in the central nervous system. Molecular and Cellular Endocrinology, 103–112. https://doi.org/10.1016/j.mce.2017.08.001Model, Z., Butler, M. P., LeSauter, J., & Silver, R. (2015). Suprachiasmatic nucleus as the site of androgen action on circadian rhythms. Hormones and Behavior, 1–7. https://doi.org/10.1016/j.yhbeh.2015.05.007Mong, J. A., & Cusmano, D. M. (2016). Sex differences in sleep: impact of biological sex and sex steroids. Philosophical Transactions of the Royal Society B: Biological Sciences, 20150110. https://doi.org/10.1098/rstb.2015.0110Morford, J. J., Wu, S., & Mauvais-Jarvis, F. (2018). The impact of androgen actions in neurons on metabolic health and disease. Molecular and Cellular Endocrinology, 92–102. https://doi.org/10.1016/j.mce.2017.09.001Morselli, L. L., Temple, K. A., Leproult, R., Ehrmann, D. A., Van Cauter, E., & Mokhlesi, B. (2018). Determinants of Slow-Wave Activity in Overweight and Obese Adults: Roles of Sex, Obstructive Sleep Apnea and Testosterone Levels. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2018.00377Mosher, L. J., Godar, S. C., Morissette, M., McFarlin, K. M., Scheggi, S., Gambarana, C., Fowler, S. C., Di Paolo, T., & Bortolato, M. (2018). Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors. Psychoneuroendocrinology, 95–104. https://doi.org/10.1016/j.psyneuen.2018.02.007Nelson, C. J., Lee, J. S., Gamboa, M. C., & Roth, A. J. (2008). Cognitive effects of hormone therapy in men with prostate cancer. Cancer, 1097–1106. https://doi.org/10.1002/cncr.23658O’Reilly, M. W., Westgate, C. S. J., Hornby, C., Botfield, H., Taylor, A. E., Markey, K., Mitchell, J. L., Scotton, W. J., Mollan, S. P., Yiangou, A., Jenkinson, C., Gilligan, L. C., Sherlock, M., Gibney, J., Tomlinson, J. W., Lavery, G. G., Hodson, D. J., Arlt, W., & Sinclair, A. J. (2019). A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. https://doi.org/10.1172/jci.insight.125348Owens, S. J., Purves-Tyson, T. D., Webster, M. J., & Shannon Weickert, C. (2019). Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder. Psychiatry Research, 112503. https://doi.org/10.1016/j.psychres.2019.112503Packard, M. G., Schroeder, J. P., & Alexander, G. M. (1998). Expression of Testosterone Conditioned Place Preference Is Blocked by Peripheral or Intra-accumbens Injection of α-Flupenthixol. Hormones and Behavior, 39–47. https://doi.org/10.1006/hbeh.1998.1461Piacentino, D., Kotzalidis, G., Casale, A., Aromatario, M., Pomara, C., Girardi, P., & Sani, G. (2015). Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review. Current Neuropharmacology, 101–121. https://doi.org/10.2174/1570159×13666141210222725Picot, M., Billard, J.-M., Dombret, C., Albac, C., Karameh, N., Daumas, S., Hardin-Pouzet, H., & Mhaouty-Kodja, S. (2016). Neural Androgen Receptor Deletion Impairs the Temporal Processing of Objects and Hippocampal CA1-Dependent Mechanisms. PLOS ONE, e0148328. https://doi.org/10.1371/journal.pone.0148328Purves-Tyson, T. D., Owens, S. J., Double, K. L., Desai, R., Handelsman, D. J., & Weickert, C. S. (2014). Testosterone Induces Molecular Changes in Dopamine Signaling Pathway Molecules in the Adolescent Male Rat Nigrostriatal Pathway. PLoS ONE, e91151. https://doi.org/10.1371/journal.pone.0091151Ramzan, F., Azam, A. B., Monks, D. A., & Zovkic, I. B. (2018). Androgen receptor is a negative regulator of contextual fear memory in male mice. Hormones and Behavior, 10–18. https://doi.org/10.1016/j.yhbeh.2018.08.012Ratner, M. H., Kumaresan, V., & Farb, D. H. (2019). Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2019.00169Rolls, E. T., & Wirth, S. (2018). Spatial representations in the primate hippocampus, and their functions in memory and navigation. Progress in Neurobiology, 90–113. https://doi.org/10.1016/j.pneurobio.2018.09.004Römer, B., Pfeiffer, N., Lewicka, S., Ben-Abdallah, N., Vogt, M. A., Deuschle, M., Vollmayr, B., & Gass, P. (2010). Finasteride Treatment Inhibits Adult Hippocampal Neurogenesis in Male Mice. Pharmacopsychiatry, 174–178. https://doi.org/10.1055/s-0030-1249095Romigi, A., Liguori, C., Placidi, F., Albanese, M., Izzi, F., Uasone, E., Terracciano, C., Marciani, M. G., Mercuri, N. B., Ludovisi, R., & Massa, R. (2014). Sleep disorders in spinal and bulbar muscular atrophy (Kennedy’s disease): a controlled polysomnographic and self-reported questionnaires study. Journal of Neurology, 889–893. https://doi.org/10.1007/s00415-014-7293-zRosario, E. R., Chang, L., Head, E. H., Stanczyk, F. Z., & Pike, C. J. (2011). Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer’s disease. Neurobiology of Aging, 604–613. https://doi.org/10.1016/j.neurobiolaging.2009.04.008Scudder, S. L., Baimel, C., Macdonald, E. E., & Carter, A. G. (2018). Hippocampal-Evoked Feedforward Inhibition in the Nucleus Accumbens. The Journal of Neuroscience, 9091–9104. https://doi.org/10.1523/jneurosci.1971-18.2018Sesack, S. R., & Grace, A. A. (2009). Cortico-Basal Ganglia Reward Network: Microcircuitry. Neuropsychopharmacology, 27–47. https://doi.org/10.1038/npp.2009.93Shahrzad, P., & Nasser, N. (2015). GABA<sub>b</sub> Receptor Antagonist (CGP<sub>35348</sub>) Improves Testosterone Induced Spatial Acquisition Impairment in Adult Male Rat. Journal of Behavioral and Brain Science, 491–502. https://doi.org/10.4236/jbbs.2015.511047Soma, M., Kim, J., Kato, A., & Kawato, S. (2018). Src Kinase Dependent Rapid Non-genomic Modulation of Hippocampal Spinogenesis Induced by Androgen and Estrogen. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2018.00282Tobiansky, D. J., Wallin-Miller, K. G., Floresco, S. B., Wood, R. I., & Soma, K. K. (2018). Androgen Regulation of the Mesocorticolimbic System and Executive Function. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2018.00279Torres, J. M., & Ortega, E. (2003). Differential regulation of steroid 5α‐reductase isozymes expression by androgens in the adult rat brain. The FASEB Journal, 1428–1433. https://doi.org/10.1096/fj.02-1119comValcamonico, F., Arcangeli, G., Consoli, F., Nonnis, D., Grisanti, S., Gatti, E., Berruti, A., & Ferrari, V. (2013). Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. International Journal of Urology, 335–337. https://doi.org/10.1111/iju.12273Wallin, K. G., & Wood, R. I. (2015). Anabolic–androgenic steroids impair set-shifting and reversal learning in male rats. European Neuropsychopharmacology, 583–590. https://doi.org/10.1016/j.euroneuro.2015.01.002Wang, S.-S., Kamphuis, W., Huitinga, I., Zhou, J.-N., & Swaab, D. F. (2008). Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Molecular Psychiatry, 786–799. https://doi.org/10.1038/mp.2008.38Williams, E. S., Manning, C. E., Eagle, A. L., Swift-Gallant, A., Duque-Wilckens, N., Chinnusamy, S., Moeser, A., Jordan, C., Leinninger, G., & Robison, A. J. (2020). Androgen-Dependent Excitability of Mouse Ventral Hippocampal Afferents to Nucleus Accumbens Underlies Sex-Specific Susceptibility to Stress. Biological Psychiatry, 492–501. https://doi.org/10.1016/j.biopsych.2019.08.006Wood, R. I. (2008). Anabolic–androgenic steroid dependence? Insights from animals and humans. Frontiers in Neuroendocrinology, 490–506. https://doi.org/10.1016/j.yfrne.2007.12.002Wu, J., Henning, P., Sjögren, K., Koskela, A., Tuukkanen, J., Movérare-Skrtic, S., & Ohlsson, C. (2019). The androgen receptor is required for maintenance of bone mass in adult male mice. Molecular and Cellular Endocrinology, 159–169. https://doi.org/10.1016/j.mce.2018.10.008Yin, J., Valin, K. L., Dixon, M. L., & Leavenworth, J. W. (2017). The Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer. Journal of Immunology Research, 1–12. https://doi.org/10.1155/2017/5150678Zarrouf, F. A., Artz, S., Griffith, J., Sirbu, C., & Kommor, M. (2009). Testosterone and Depression. Journal of Psychiatric Practice, 289–305. https://doi.org/10.1097/01.pra.0000358315.88931.fcZhao, R., Wang, X., Jiang, C., Shi, F., Zhu, Y., Yang, B., Zhuo, J., Jing, Y., Luo, G., Xia, S., & Han, B. (2017). Finasteride accelerates prostate wound healing after thulium laser resection through DHT and AR signalling. Cell Proliferation, e12415. https://doi.org/10.1111/cpr.12415